TOKAI (9729) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY2027 net sales reached a record ¥82,111mn (+3.9% YoY); operating profit rose 11.5% to ¥4,920mn and parent-attributable profit rose 10.2% to ¥3,351mn.
Full-year operating and ordinary profit forecasts were raised from expected YoY declines to growth; the FY3/28 operating profit target of ¥9.5bn is expected to be achieved a year early.
Financial highlights
H1 net sales were ¥82,111mn versus ¥79,026mn; gross profit was ¥20,460mn versus ¥19,023mn.
Operating profit was ¥4,920mn versus ¥4,410mn; ordinary profit was ¥5,170mn versus ¥4,674mn.
Parent-attributable profit was ¥3,351mn versus ¥3,040mn; basic EPS was ¥108.50 versus ¥89.89, and comprehensive income was ¥4,148mn versus ¥3,946mn.
Outlook and guidance
Revised FY2027 forecasts: net sales ¥167,980mn (+5.2% YoY), operating profit ¥10,286mn (+9.6%), ordinary profit ¥10,716mn (+6.1%), parent-attributable profit ¥6,866mn (+13.1%); full-year basic EPS forecast is ¥222.25.
Forecast operating profit increased ¥1,301mn and ordinary profit ¥1,278mn versus initial forecasts; the results forecast was unchanged from the latest announcement.
FY2027 dividend forecast is ¥89 per share, comprising ¥40 at the second-quarter end and ¥49 at fiscal year-end; this is ¥9 above initial guidance and ¥21 higher YoY.
The FY3/28 operating profit target of ¥9.5bn is expected to be met one year early; a revised target is planned after review.
Latest events from TOKAI
- Record quarterly sales and profits, with higher dividends and new business set to drive growth.9729
Q1 2027 - Record sales and profit growth, with higher dividends and a slight profit dip forecasted.9729
Q4 2026 - Record sales and profit growth, driven by rental, pharmacy, M&A, and special dividends.9729
Q3 2026 - Record sales and profit growth, higher dividends, and capital returns planned.9729
Q2 2026 - Record sales and operating profit, but net profit fell; outlook and dividend raised.9729
Q1 2026 - Net sales and net income increased, but full-year profit is forecast to decline.9729
Q2 2025 - Sales and profits rose, with strong Q1 gains and stable full-year outlook.9729
Q1 2025 - Record sales and profit growth, but net income fell on impairments; outlook remains positive.9729
Q4 2025 - Record sales growth, but profit pressured by higher costs and securities losses.9729
Q3 2025